Sign In
Buy NEO
$10.14
+0.0200 (+0.198%)
At Close: Jun 03, 2026
Needham Keeps a Buy Rating on NeoGenomics (NEO)
11:06am, Wednesday, 29'th Apr 2020
In a report released today, Stephen Unger from Needham maintained a Buy rating on NeoGenomics (NEO), with a price target of $33.00. The company's shares
Needham Keeps a Buy Rating on NeoGenomics (NEO)
11:06am, Wednesday, 29'th Apr 2020
In a report released today,
Stephen Unger
from Needham maintained a
Buy
rating on NeoGenomics (
NEO
–
Research Report
), with a price target of
$33.00
. The company’s shares closed last Tuesday at
NeoGenomics (NEO) Receives a Buy from Leerink Partners
10:58am, Wednesday, 29'th Apr 2020
Leerink Partners analyst Puneet Souda maintained a Buy rating on NeoGenomics (NEO) today and set a price target of $35.00. The company's shares closed
NeoGenomics (NEO) Receives a Buy from Leerink Partners
10:57am, Wednesday, 29'th Apr 2020
Leerink Partners analyst
Puneet Souda
maintained a
Buy
rating on NeoGenomics (
NEO
–
Research Report
) today and set a price target of
$35.00
. The company’s shares closed last Tuesday at $27.97.
NeoGenomics Prioritizes the Public Good During COVID-19 Slowdown
10:33am, Wednesday, 29'th Apr 2020
Despite experiencing a double-digit decline in test volumes, the cancer genetics lab hasn't furloughed employees. It has even retooled labs to process COVID-19 swab and blood tests.
NeoGenomics : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS | MarketScreener
10:29am, Wednesday, 29'th Apr 2020SVB Leerink Maintains Outperform on NeoGenomics, Raises Price Target to $35
10:17am, Wednesday, 29'th Apr 2020Neogenomics Inc (NASDAQ: NEO) Q1 2020 Earnings Call Transcript | AlphaStreet
09:37pm, Tuesday, 28'th Apr 2020
Final earnings conference call transcript of Neogenomics Inc. - NEO stock
Neogenomics Inc (NEO) Q1 2020 Earnings Call Transcript
08:00pm, Tuesday, 28'th Apr 2020
NEO earnings call for the period ending March 31, 2020.
Neogenomics Inc. (NEO) CEO Doug VanOort on Q1 2020 Results - Earnings Call Transcript
07:23pm, Tuesday, 28'th Apr 2020
Neogenomics Inc. (NASDAQ:NEO) Q1 2020 Earnings Conference Call April 28, 2020 08:30 ET Company Participants Doug VanOort - Chief Executive Officer Kathryn McKen
NeoGenomics (NEO) Reports Q1 Loss, Misses Revenue Estimates
01:35pm, Tuesday, 28'th Apr 2020
NeoGenomics (NEO) delivered earnings and revenue surprises of -200.00% and -0.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NeoGenomics (NEO) Reports Q1 Loss, Misses Revenue Estimates
01:35pm, Tuesday, 28'th Apr 2020
NeoGenomics (NEO) delivered earnings and revenue surprises of -200.00% and -0.02%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
NeoGenomics: 1Q Earnings Snapshot
12:26pm, Tuesday, 28'th Apr 2020
FORT MYERS, Fla. (AP) _ NeoGenomics Inc. (NEO) on Tuesday reported a loss of $7 million in its first quarter.
On a per-share basis, the Fort Myers, Florida-based company said it had a loss of 7 cents.
